Daniel Frigo, University of Houston (2 of 3) (IMAGE)
Caption
Daniel Frigo and his team are working to develop the next generation of prostate cancer therapies targeted at metabolism.
Credit
Jessie Villarreal
Usage Restrictions
None
License
Licensed content